Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2005; 45:1611-1619, doi:10.1016/j.jacc.2005.01.051
© 2005 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (28)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, S. N.
Right arrow Articles by Marian, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, S. N.
Right arrow Articles by Marian, A. J.
Related Collections
Right arrowRelated Article

CLINICAL RESEARCH: ATHEROSCLEROSIS

A Common PCSK9 Haplotype, Encompassing the E670G Coding Single Nucleotide Polymorphism, Is a Novel Genetic Marker for Plasma Low-Density Lipoprotein Cholesterol Levels and Severity of Coronary Atherosclerosis

Suet N. Chen, MS*, Christie M. Ballantyne, MD, FACC*, Antonio M. Gotto, Jr, MD, DPhil, FACC{dagger}, Yanli Tan, RN*, James T. Willerson, MD, FACC{ddagger} and Ali J. Marian, MD, FACC*,*

* Sections of Cardiology and Atherosclerosis, Center for Preventive Cardiology, Department of Medicine, Baylor College of Medicine, Houston, Texas
{dagger} Weill Medical College of Cornell University, New York, New York
{ddagger} University of Texas Health Science Center, Houston, Texas

Manuscript received October 14, 2004; revised manuscript received January 4, 2005, accepted January 11, 2005.

* Reprint requests and correspondence: Dr. Ali J. Marian, Baylor College of Medicine, Section of Cardiology, One Baylor Plaza, 519D, Houston, Texas 77030 (Email: amarian{at}bcm.tmc.edu).

OBJECTIVES: We sought to determine the effects of PCSK9 variants on plasma low-density lipoprotein cholesterol (LDL-C) levels, severity of coronary atherosclerosis, and response to statin therapy in the Lipoprotein Coronary Atherosclerosis Study (LCAS) population.

BACKGROUND: Mutations in PCSK9 cause autosomal-dominant hypercholesterolemia. We hypothesized that PCSK9 variants could affect plasma LDL-C in individuals with polygenic hypercholesterolemia.

METHODS: We sequenced all 12 exons and boundaries to detect novel polymorphisms, and genotyped 372 subjects in LCAS and 319 subjects in a second independent population for six polymorphisms, including novel leucine repeats, by fluorescently tagged markers. We reconstructed haplotypes using a Bayesian algorithm.

RESULTS: Permutation test results showed statistically significant differences in global haplotype distribution among the tertiles of LDL-C (odds ratio [OR]: 2.36, 95% confidence interval [CI]: 1.90 to 4.32, p = 0.005) and minimum lumen diameter of coronary lesions (OR: 1.83, 95% CI: 1.01 to 3.55, p = 0.045). Regression analysis identified haplotype 3 as an independent determinant of LDL-C levels (adjusted R2 = 2.2%, F = 9.37, p = 0.002). Haplotype structure analysis identified E670G as the determinant variant, exerting a dose effect (GG > EG > EE) and accounting for 3.5% of plasma LDL-C variability (F = 14.6, p < 0.001). Plasma total cholesterol, apolipoprotein B, and lipoprotein (a) levels were also associated with the E670G variant. Distributions of the E670G genotypes in an independent normolipidemic and the hyperlipidemic LCAS populations were significantly different (F = 7.2, p = 0.027). No significant treatment-by-genotype interactions were detected. The false positive report probability was between 2% and 8%.

CONCLUSIONS: Haplotype 3 encompassing the E670G variant is an independent determinant of plasma LDL-C levels and the severity of coronary atherosclerosis.

Abbreviations and Acronyms
  ADH = autosomal-dominant hypercholesterolemia
  FPRP = false positive report probability
  HDL-C = high-density lipoprotein cholesterol
  HWE = Hardy-Weinberg equilibrium
  LCAS = Lipoprotein Coronary Atherosclerosis Study
  LDL-C = low-density lipoprotein cholesterol
  Lp(a) = lipoprotein (a)
  MAF = minor allele frequencies
  MI = myocardial infarction
  PCR = polymerase chain reaction
  PL-EM = partition-ligation-expectation-maximization
  SNP = single nucleotide polymorphism
  STR = short tandem repeat
  TC = total cholesterol
  TG = triglycerides


Related Article

What Promise Does PCSK9 Hold?
John J.P. Kastelein, Sigrid W. Fouchier, and Joep C. Defesche
J. Am. Coll. Cardiol. 2005 45: 1620-1621. [Full Text] [PDF]



This article has been cited by other articles:


Home page
Circ Cardiovasc GenetHome page
C.-C. Huang, M. Fornage, D. M. Lloyd-Jones, G. S. Wei, E. Boerwinkle, and K. Liu
Longitudinal Association of PCSK9 Sequence Variations With Low-Density Lipoprotein Cholesterol Levels: The Coronary Artery Risk Development in Young Adults Study
Circ Cardiovasc Genet, August 1, 2009; 2(4): 354 - 361.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
S. D. Horswell, H. E. Ringham, and C. C. Shoulders
New technologies for delineating and characterizing the lipid exome: prospects for understanding familial combined hyperlipidemia
J. Lipid Res., April 1, 2009; 50(Supplement): S370 - S375.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
M Abifadel, L Bernier, G Dubuc, G Nuel, J-P Rabes, J Bonneau, A Marques, M Marduel, M Devillers, A Munnich, et al.
A PCSK9 variant and familial combined hyperlipidaemia
J. Med. Genet., December 1, 2008; 45(12): 780 - 786.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
K. E. North, H. H. H. Goring, S. A. Cole, V. P. Diego, L. Almasy, S. Laston, T. Cantu, B. V. Howard, E. T. Lee, L. G. Best, et al.
Linkage analysis of LDL cholesterol in American Indian populations: the Strong Heart Family Study
J. Lipid Res., January 1, 2006; 47(1): 59 - 66.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. J.P. Kastelein, S. W. Fouchier, and J. C. Defesche
What Promise Does PCSK9 Hold?
J. Am. Coll. Cardiol., May 17, 2005; 45(10): 1620 - 1621.
[Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement